CD8A and neoplasm: Paired samples of CD8+ T cells derived from different sites were available as follows: PBMC and intrahepatic lymphocytes (IHL), 10 patients; PBMC and tumor‐infiltrating lymphocytes (TIL), 17 patients; IHL and TIL, six patients.